Targeting 14-3-3 Sensitizes Native and Mutant BCR-ABL to Inhibition With U0126, Rapamycin and BCL-2 Inhibitor GX15-070

Leukemia - United Kingdom
doi 10.1038/sj.leu.2405064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search